drugset / Trial / NCT03801122
Evolution of Thromboelastography During Tranexamic Acid Treatment
Phase 2
Completed
18 enrolled
University Hospital of Saint-Etienne
Institut de Cancérologie de la Loire · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Patients with hematological malignancies are at increased risk of bleeding, especially during intensive chemotherapy. The aim of this study is to compare by thromboelastography changes during the intensive chemotherapy in patients with hematological malignancies.
Timeline
- Start
- 2019-03-05
- Primary completion
- 2022-03-09
- Completion
- 2022-07-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1.5 g | Other |
| Subject | Tranexamic Acid | Small molecule | 3 g | Other |